Alto Neuroscience Balance Sheet (2023-2026) | ANRO

Balance Sheet Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 82.50M205.90M193.12M181.70M168.20M160.75M147.59M137.82M176.48M263.76M
Cash & Current Investments (Quarter) 82.50M205.90M193.12M181.70M168.20M160.75M147.59M137.82M176.48M263.76M
Receivables - Other (Quarter) 0.01M
Prepaid Assets (Quarter) 2.84M2.42M2.29M0.28M1.11M2.77M2.26M1.63M1.23M5.36M
Current Assets (Quarter) 85.39M208.31M195.41M183.53M169.34M163.52M149.85M139.45M177.72M269.13M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 1.11M1.55M1.44M2.35M2.67M2.48M2.31M2.03M1.87M2.23M
Other Non-Current Assets (Quarter) 0.06M0.00M0.50M0.50M0.50M0.57M0.50M0.34M0.50M
Non-Current Assets (Quarter) 1.24M1.61M1.95M8.08M8.21M8.39M8.03M7.56M6.97M7.13M
Assets (Quarter) 86.63M209.92M197.36M191.61M177.54M171.91M157.88M147.01M184.69M276.26M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 1.07M2.41M1.84M2.25M1.58M1.38M1.67M2.06M1.88M3.37M
Payables (Quarter) 1.07M2.41M1.84M2.25M1.58M1.38M1.67M2.06M1.88M3.37M
Accumulated Expenses (Quarter) 4.54M4.45M5.68M8.23M8.43M5.87M6.46M6.99M8.86M7.61M
Short term Debt (Quarter) 1.15M2.32M3.53M0.58M2.14M
Total Current Liabilities (Quarter) 5.61M8.01M9.84M14.02M10.01M7.26M8.13M9.04M11.32M13.12M
Non-Current Liabilities
Non-Current Debt (Quarter) 9.86M8.81M7.74M6.63M10.25M19.94M20.12M20.31M16.17M13.88M
Convertible Debt (Quarter) 1.30M1.30M1.21M2.00M2.12M2.23M2.33M
Preferred Stock Liabilities (Quarter) 97.08M97.08M97.08M141.48M
Operating Leases (Quarter) 5.20M5.39M4.41M4.21M3.97M3.82M3.56M
Other Non-Current Liabilities (Quarter) 1.70M1.60M1.40M1.35M
Total Non-Current Liabilities (Quarter) 43.52M51.00M59.70M15.47M16.82M17.58M26.56M26.08M
Total Liabilities (Quarter) 45.23M52.60M61.10M16.82M16.82M17.58M26.56M26.08M32.82M34.47M35.45M33.55M32.89M
Shareholder's Equity
Total Debt (Quarter) 9.86M9.96M10.06M10.16M10.25M19.94M20.12M20.31M16.76M16.02M
Common Equity (Quarter) -45.23M-52.60M-61.10M-71.67M193.10M179.78M165.05M151.46M139.10M123.41M111.56M151.14M243.37M
Shareholder's Equity (Quarter) -45.23M-52.60M-61.10M-71.67M193.10M179.78M165.05M151.46M139.10M123.41M111.56M151.14M243.37M
Liabilities and Shareholders Equity (Quarter) 86.63M209.92M197.36M191.61M177.54M171.91M157.88M147.01M184.69M276.26M
Retained Earnings (Quarter) -0.08M-0.08M-106.40M-0.10M-0.10M-153.60M-171.30M-185.45M-201.63M-227.90M
Treasury Shares (Quarter) 0.59M0.05M0.05M0.05M0.05M0.03M0.03M